91 related articles for article (PubMed ID: 1525636)
1. HLA-DR3, C4A*QO and toxicity from gold in rheumatoid arthritis.
Cohen MG; Li EK; Ng PY
Br J Rheumatol; 1992 Sep; 31(9):645. PubMed ID: 1525636
[No Abstract] [Full Text] [Related]
2. Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis.
Clarkson RW; Sanders PA; Grennan DM
Br J Rheumatol; 1992 Jan; 31(1):53-4. PubMed ID: 1730108
[TBL] [Abstract][Full Text] [Related]
3. Coeliac disease and C4A*QO: an association secondary to HLA-DR3.
Rittner C; DeMarchi M; Mollenhauer E; Carbonara A
Tissue Antigens; 1984 Feb; 23(2):130-4. PubMed ID: 6608806
[No Abstract] [Full Text] [Related]
4. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria.
Singal DP; Reid B; Green D; D'Souza M; Bensen WG; Buchanan WW
Ann Rheum Dis; 1990 Aug; 49(8):582-6. PubMed ID: 2396862
[TBL] [Abstract][Full Text] [Related]
6. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
Fielder AH; Walport MJ; Batchelor JR; Rynes RI; Black CM; Dodi IA; Hughes GR
Br Med J (Clin Res Ed); 1983 Feb; 286(6363):425-8. PubMed ID: 6401549
[TBL] [Abstract][Full Text] [Related]
7. Gold induced thrombocytopenia: 12 cases and a review of the literature.
Adachi JD; Bensen WG; Kassam Y; Powers PJ; Bianchi FA; Cividino A; Kean WF; Rooney PJ; Craig GL; Buchanan WW
Semin Arthritis Rheum; 1987 May; 16(4):287-93. PubMed ID: 3110956
[TBL] [Abstract][Full Text] [Related]
8. Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.
McCann VJ; McCluskey J; Kelly H; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
Diabetologia; 1984 Jul; 27 Suppl():124-5. PubMed ID: 6332753
[TBL] [Abstract][Full Text] [Related]
9. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis.
Avila-Portillo LM; Vargas-Alarcón G; Andrade F; Alarcón-Segovia D; Granados J
Clin Exp Rheumatol; 1994; 12(5):497-502. PubMed ID: 7842529
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and drug toxicity in rheumatoid arthritis.
Ford PM
J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749
[No Abstract] [Full Text] [Related]
12. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
13. Patients with rheumatoid arthritis and gold-induced pneumonitis express two high-risk major histocompatibility complex patterns.
Partanen J; van Assendelft AH; Koskimies S; Forsberg S; Hakala M; Ilonen J
Chest; 1987 Aug; 92(2):277-81. PubMed ID: 3111796
[TBL] [Abstract][Full Text] [Related]
14. DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus.
Kumar A; Kumar P; Schur PH
Clin Immunol Immunopathol; 1991 Jul; 60(1):55-64. PubMed ID: 2044237
[TBL] [Abstract][Full Text] [Related]
15. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
[TBL] [Abstract][Full Text] [Related]
16. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
Regueiro JR; Arnaiz-Villena A
Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
[TBL] [Abstract][Full Text] [Related]
17. Complement C4B-null alleles in Felty's syndrome.
Thomson W; Sanders PA; Davis M; Davidson J; Dyer PA; Grennan DM
Arthritis Rheum; 1988 Aug; 31(8):984-9. PubMed ID: 3261591
[TBL] [Abstract][Full Text] [Related]
18. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Koreans.
Park MH; Oh MD; Song YW; Pai HJ; Takeuchi F; Tokunaga K; Hong GH; Park KS
Ann Rheum Dis; 1996 Oct; 55(10):776-8. PubMed ID: 8984946
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype.
Ulgiati D; Abraham LJ
Exp Clin Immunogenet; 1996; 13(1):43-54. PubMed ID: 8854088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
